|Mr. Scott Dunbar||Acting Chief Exec. Officer||255.3k||N/A||1958|
|Mr. Edward Jonathon Sedo||Acting Chief Accounting Officer & Principal Financial Officer||151.08k||N/A||1956|
|Mr. Edward David Randolph||VP of Operations||167.5k||N/A||1958|
|Dr. Jessy Dana Dorn Ph.D.||VP of Clinical & Scientific Affairs||233.99k||N/A||1976|
|Ms. Lisa M. Wilson||Founder & Pres of In-Site Communications and Investor Relations for Second Sight||N/A||N/A||1965|
Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. The company was founded in 1998 and is headquartered in Sylmar, California.
Second Sight Medical Products, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.